Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
21
pubmed:dateCreated
2008-7-21
pubmed:abstractText
The treatment of patients with follicular lymphoma has changed with the introduction of high-dose therapy (HDT) with autologous stem-cell transplant then with rituximab. The effect of these two strategies on the outcome of relapsing patients with follicular lymphoma has never been compared.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1527-7755
pubmed:author
pubmed:issnType
Electronic
pubmed:day
20
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3614-20
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:18559872-Adult, pubmed-meshheading:18559872-Aged, pubmed-meshheading:18559872-Antibodies, Monoclonal, pubmed-meshheading:18559872-Antibodies, Monoclonal, Murine-Derived, pubmed-meshheading:18559872-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:18559872-Combined Modality Therapy, pubmed-meshheading:18559872-Disease-Free Survival, pubmed-meshheading:18559872-Female, pubmed-meshheading:18559872-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:18559872-Humans, pubmed-meshheading:18559872-Kaplan-Meier Estimate, pubmed-meshheading:18559872-Lymphoma, Follicular, pubmed-meshheading:18559872-Male, pubmed-meshheading:18559872-Middle Aged, pubmed-meshheading:18559872-Neoplasm Recurrence, Local, pubmed-meshheading:18559872-Randomized Controlled Trials as Topic, pubmed-meshheading:18559872-Recurrence, pubmed-meshheading:18559872-Retrospective Studies, pubmed-meshheading:18559872-Salvage Therapy, pubmed-meshheading:18559872-Transplantation, Autologous
pubmed:year
2008
pubmed:articleTitle
Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study.
pubmed:affiliation
Centre Léon Bérard, Lyon, France.
pubmed:publicationType
Journal Article